Press Releases Search View

Select Category

Recent News

Search By:

Search By Release Date

100 Record(s) Found. Displaying Page 1:

1 2 3 4 5 [Next >>]

VGXI Expands Manufacturing Facility, Adds Key Personnel
Print \| More options ▼ View RSS Feed
Release Date: 9-Mar-10 Author or Contact: David Colvin
NEW ORLEANS--(BUSINESS WIRE)--Mar 4, 2010 - VGXI, Inc., a leading provider of DNA plasmid manufacturing and development services, announced today at the 2010 DNA Vaccines Conference the expansion of its state-of-the-art cGMP plasmid manufacturing facility in The Woodlands, TX. "This expansion nearly doubles the size of our current facility putting us in a much better position to meet the growing demand for our research and cGMP manufacturing ...
Click to read VGXI Expands Manufacturing Facility, Adds Key Personnel

Lexicon to put $95M in shares on sales block
Print \| More options ▼ View RSS Feed
Release Date: 8-Mar-10 Author or Contact:
Lexicon Pharmaceuticals Inc.'s shares slid 9 percent Monday after the biopharmaceutical firm announced plans to offer $95 million of its stock to the public. Lexicon (NASDAQ: LXRX) has granted underwriters up to $14.25 million in shares to cover any over-allotments. The Woodlands company’s shares closed March 5 at $1.78 per share. It has 175.7 million shares outstanding. Morgan Stanley & Co. Inc. and J.P. Morgan Securities Inc. will ...
Click to read Lexicon to put $95M in shares on sales block

UTSA opens New Venture Incubator on campus
Print \| More options ▼ View RSS Feed
Release Date: 8-Mar-10 Author or Contact:
The University of Texas at San Antonio has opened a new facility on campus that will offer office and laboratory space to technology entrepreneurs as a way to help them grow their companies. The UTSA Center for Innovation and Technology Entrepreneurship opened up the New Venture Incubator as part of its ongoing efforts to foster the development of more home-grown tech firms. The New Venture Incubator is located on UTSA’s Main Campus and ...
Click to read UTSA opens New Venture Incubator on campus

KCI gains approval to expand to Japanese wound-care market
Print \| More options ▼ View RSS Feed
Release Date: 8-Mar-10 Author or Contact:
Japanese health insurance regulators have approved Kinetic Concepts Inc.’s wound-care system for reimbursement. Japanese physicians who prescribe the company’s V.A.C. Therapy System, will be able to get reimbursed by the government. This move by the government clears the way for Kinetic Concepts (KCI) to have its products sold in Japan. With this approval in hand from Japan’s Health Insurance Bureau, KCI expects to begin ...
Click to read KCI gains approval to expand to Japanese wound-care market

Stem Cell Innovations to Provide Research and Assay Services to Agennix Read more: http://www.fiercebiotech.com/press-releases/stem-cell-innovations-provide-research-and-assay-services-agennix-0#ixzz
Print \| More options ▼ View RSS Feed
Release Date: 3-Mar-10 Author or Contact:
HOUSTON, March 2 /PRNewswire-FirstCall/ -- Stem Cell Innovations (Pink Sheets: SCLL) announced today that the Company has signed a Master Services Agreement to provide research and assay services in support of Agennix's talactoferrin program. The assay utilizes SCLL's C3A human liver cell line. "We are happy to enter into this contract with Agennix," said James H. Kelly, PhD, CEO of Stem Cell Innovations. "Our C3A cells provide a reliable and ...
Click to read Stem Cell Innovations to Provide Research and Assay Services to Agennix Read more: http://www.fiercebiotech.com/press-releases/stem-cell-innovations-provide-research-and-assay-services-agennix-0#ixzz

Vidacare unveils bone marrow extraction device in U.S.
Print \| More options ▼ View RSS Feed
Release Date: 3-Mar-10 Author or Contact:
Vidacare Corp. has released its OnControl Bone Marrow System. The company developed this system with an eye toward raising the standard of care for bone marrow patients, while alleviating much of the pain of traditional procedures. Vidacare officials developed its system using its patented lithium battery-power driver. The OnControl Bone Marrow System is designed to quickly drill a needle directly into the marrow of a patient and ...
Click to read Vidacare unveils bone marrow extraction device in U.S.

Mission Pharmacal rolls out new product to help alleviate morning sickness
Print \| More options ▼ View RSS Feed
Release Date: 1-Mar-10 Author or Contact:
Mission Pharmacal Co. has developed a new vitamin supplement designed to help reduce the amount of morning sickness women face during pregnancy. The San Antonio company created a new B6-rich prescription prenatal vitamin, called CitraNatal B-Calm. It’s designed to boost a woman’s defense system against pregnancy-related nausea and vomiting. The scientific literature from the American College of Obstetricians and Gynecologists ...
Click to read Mission Pharmacal rolls out new product to help alleviate morning sickness

A&M gets big grant to make tobacco-based vaccine
Print \| More options ▼ View RSS Feed
Release Date: 24-Feb-10 Author or Contact:
The Texas A&M University System and a Texas company have been awarded a $40 million U.S. Department of Defense grant to develop vaccines made from tobacco, a hoped-for improvement on the antiquated egg-based technology that made the response to last year's swine flu outbreak so slow. The so-called Texas Plant-Expressed Vaccine Consortium announced the manufacturing initiative Wednesday. It will be headquartered in a 145,000-square-foot facility ...
Click to read A&M gets big grant to make tobacco-based vaccine

MicroTransponder Inc. raises $7M
Print \| More options ▼ View RSS Feed
Release Date: 24-Feb-10 Author or Contact:
Medical device developer MicroTransponder Inc. raised $7 million Series B round financing for its next clinical trial, according to a press release today. The Austin company is testing a wireless neurostimulation platform that will treat chronic pain and other neurological indications. MicroTransponder did not name the investors, but said the latest contribution came from existing funders and angel investors. At the same time, the ...
Click to read MicroTransponder Inc. raises $7M

Cyberonics approves share buyback program
Print \| More options ▼ View RSS Feed
Release Date: 18-Feb-10 Author or Contact:
The board of Cyberonics Inc. has approved a new share repurchase program of up to 1 million shares. This replaces an older buyback program of 1 million shares. The Houston medical technology company repurchased 515,000 shares under the program. Cyberonics (NASDAQ: CYBX) expects to complete this program by the end of fiscal 2011. The company has about 27.7 million shares outstanding.
Click to read Cyberonics approves share buyback program

Mission Pharmacal retools kidney stone drug
Print \| More options ▼ View RSS Feed
Release Date: 17-Feb-10 Author or Contact:
Mission Pharmacal Co. has developed a new formulation of its drug compound for kidney stone treatment. The San Antonio company’s new Urocit-K 15 mEq extended-release tablet has been developed with a maximum-strength alkalinizing agent that has been shown to help prevent kidney stone recurrence in more than 90 percent of patients. “The availability of Urocit-K 15 mEq is important for kidney stone patients because it can help ease ...
Click to read Mission Pharmacal retools kidney stone drug

Stematix inks deal with Argentine firm
Print \| More options ▼ View RSS Feed
Release Date: 15-Feb-10 Author or Contact:
Stematix Inc. has signed a 10-year agreement with Laboratorios Bagó to distribute certain Stematix products. Financial terms of the deal were not disclosed, however Houston-based Stematix has the option of additional forms of joint collaboration in clinical trials and treatments with Laboratorios Bagó, a medical products company based in Buenos Aires, Argentina. As part of the deal, Laboratorios Bagó will distribute a variety ...
Click to read Stematix inks deal with Argentine firm

Luminex Corp. reports record growth
Print \| More options ▼ View RSS Feed
Release Date: 5-Feb-10 Author or Contact:
Testing equipment maker Luminex Corp. reported $20 million in fourth quarter income on $38.1 million in revenue, which compares with $2 million in income on $28.1 million in revenue the same period last year. Austin-based Luminex (Nasdaq:LMNX) reported that the 35 percent year-to-year revenue growth was the highest ever logged by the company. Luminex, which was founded in 1995, employs about 380 workers. The company develops biological ...
Click to read Luminex Corp. reports record growth

GenSpera awarded patent for prospective prostate cancer drug
Print \| More options ▼ View RSS Feed
Release Date: 2-Feb-10 Author or Contact:
The U.S. Patent and Trademark Office issued a new patent to GenSpera Inc. to cover the intellectual property on the company’s second anti-cancer drug compound currently in development. The patent 7,635,682 covers GenSpera’s drug G-115 — which is activated in prostate tumors by an enzyme. In preclinical testing, G-115 was shown to inhibit the growth of tumors in animal models of prostate cancer. Obtaining the patent rights to ...
Click to read GenSpera awarded patent for prospective prostate cancer drug

Repros Therapeutics gets verbal OK for drug trial
Print \| More options ▼ View RSS Feed
Release Date: 2-Feb-10 Author or Contact:
Repros Therapeutics Inc. has been given a verbal go-ahead from the U.S. Food and Drug Administration to initiate its investigational new drug application for the study of its male infertility drug Androxal in the treatment of men with Type II diabetes. The Woodlands-based Repros (NASDAQ: RPRX) plans to enroll a total of 60 men into Phase IIa clinical trials to compare the reactions to a placebo to two active doses of the drug. Dr. Glenn ...
Click to read Repros Therapeutics gets verbal OK for drug trial

Beckman Coulter to shutter Webster facility
Print \| More options ▼ View RSS Feed
Release Date: 1-Feb-10 Author or Contact:
Beckman Coulter Inc. is closing its facility in Webster and laying off 19 people over the next few months. In a letter to the Texas Workforce Commission, Beckman Coulter (NYSE: BEC) said the facility will close around Oct. 10. Between now and then, the Brea, Calif.-based biomedical testing company does expect more layoffs although it did not specifically state how many. Many of the people being let go in this round, either on March 31 or ...
Click to read Beckman Coulter to shutter Webster facility

AirStrip names executive to lead product sales
Print \| More options ▼ View RSS Feed
Release Date: 1-Feb-10 Author or Contact:
Health technology company AirStrip Technologies has hired a new chief sales officer to drive sales of its remote patient monitoring products. Bruce Brandes comes to AirStrip from HealthStream Inc., where he was vice president of sales and field operations. HealthStream is a software-as-a-service health care company. “Bruce knows the health care industry inside and out, and is especially skilled at building both sales infrastructure and ...
Click to read AirStrip names executive to lead product sales

Pioneer Surgical Technology opening Austin office
Print \| More options ▼ View RSS Feed
Release Date: 29-Jan-10 Author or Contact:
A Michigan-based medical device company will open an Austin facility in April, officials said this morning. Pioneer Surgical Technology Inc. did not say how many jobs would be created or where the local office would be, but it will house its spine development division. Officials said they chose Austin because of the city's rich access to key spine markets and surgical support. Central Texas has several prominent spine resources including ...
Click to read Pioneer Surgical Technology opening Austin office

GenSpera enrolls first patient in cancer trial
Print \| More options ▼ View RSS Feed
Release Date: 28-Jan-10 Author or Contact:
GenSpera Inc. has reached a milestone in the development of its investigational cancer drug. In a phase 1 clinical study, doctors at the University of Wisconsin Carbone Cancer Center in Madison treated the first patient with GenSpera’s cancer chemotherapeutic agent G-202. The phase 1 clinical study is designed to treat up to 30 patients with cancers that have progressed even after treatment with other anti-cancer therapies. The study ...
Click to read GenSpera enrolls first patient in cancer trial

Repros shares spike after FDA meeting
Print \| More options ▼ View RSS Feed
Release Date: 27-Jan-10 Author or Contact:
Repros Therapeutics Inc.’s shares soared Wednesday afternoon as the biopharmaceutical company received advice from the Food and Drug Administration on how to deal with its male infertility drug Androxal. At the highest, Repros’ shares were up 77 percent to $1.22 from Jan. 26’s close of 69 cents. Shares closed Wednesday above 90 cents. The stock has traded as high as $11.35 in the past year. In a meeting with the company, ...
Click to read Repros shares spike after FDA meeting

1 2 3 4 5 [Next >>]

Contact Us | Site Map |

| OPML | Search This Site | Home
Schipul Web Design | Houston Social Media | Tendenci� Content Management Software | Privacy | Terms and Conditions